Social Affairs

[Photo] Opening Day of the 31st Busan International Film Festival (BIFF)

Bang In-Kwon
2026-10-06 12:14:24
[Edaily Reporter Bang In-kwon] On the 6th, the opening day of the 31st Busan International Film Festival (BIFF), information on the films to be screened is displayed in front of the Busan Cinema Center in Haeundae-gu, Busan. Now in its 31st year, the Busan International Film Festival will screen a total of 315 films—including 246 officially invited titles from 59 countries—at 31 screens across eight theaters, including the Busan Cinema Center, through the 15th.

[E-Daily Reporter Bang In-kwon] On the 6th, the opening day of the 31st Busan International Film Festival (BIFF), information on the films to be screened is displayed in front of the Busan Cinema Center in Haeundae-gu, Busan.
Marking its 31st edition this year, the Busan International Film Festival will screen a total of 315 films—including 246 officially invited titles from 59 countries—on 31 screens across eight theaters, including the Busan Cinema Center, through the 15th.

Economy

Corporation

IT·Science

Economy

Samsung Electro-Mechanics Secures Additional MLCC Orders Worth 285.6 Billion Won… Supply Contracts Estimated at About 4 Trillion Won This Year (Comprehensive)

Samsung Electro-Mechanics has signed a 285.6 billion won supply contract for multilayer ceramic capacitors (MLCCs) with a major global corporation. As demand for high-performance MLCCs is rapidly incr…
2026-10-06 12:08:48

Corporation

From promotional material production to contract review… Companies are cutting outsourcing contracts and hiring 'AI-trained employees'

#Public relations agency A has recently been requiring its employees to take training in “vibe coding” (a method in which a person describes the required functions in natural language, and generative …
2026-10-06 14:32:10

IT·Science

MedPacto, Inc. Receives Approval for Phase 1 Clinical Trial of ‘MP2021’ in Australia… “Secures Second Clinical Pipeline”

MedPacto, Inc. Research Institute (Photo: MedPacto, Inc.) MedPacto, Inc.(235980)announced on the 6th that it has received approval for the Phase 1 clinical trial plan (IND) for “MP2021,” a drug ca…
2026-10-06 14:51:02